|
Volumn 41, Issue 32, 2002, Pages 10304-10314
|
Toward a PKB inhibitor: Modification of a selective PKA inhibitor by rational design
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RATIONAL DESIGN;
BIOASSAY;
CELLS;
LEAD COMPOUNDS;
PROTEINS;
TUMORS;
BIOCHEMISTRY;
AKSTATIN;
CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR;
N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE;
NL 71 101;
PROTEIN KINASE B;
PROTEIN KINASE B INHIBITOR;
UNCLASSIFIED DRUG;
APOPTOSIS;
ARTICLE;
CELL LINE;
COMBINATORIAL LIBRARY;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG SPECIFICITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
RADIOACTIVITY;
REACTION ANALYSIS;
STRUCTURE ANALYSIS;
TUMOR CELL;
3T3 CELLS;
ADENOSINE TRIPHOSPHATE;
ANIMALS;
APOPTOSIS;
BINDING, COMPETITIVE;
CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE;
CELL LINE;
COMBINATORIAL CHEMISTRY TECHNIQUES;
CYCLIC AMP-DEPENDENT PROTEIN KINASES;
ENZYME INHIBITORS;
GLYCOGEN SYNTHASE KINASE 3;
HUMANS;
ISOQUINOLINES;
MICE;
PHOSPHORYLATION;
PROTEIN-SERINE-THREONINE KINASES;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-AKT;
STRUCTURE-ACTIVITY RELATIONSHIP;
SUBSTRATE SPECIFICITY;
SULFONAMIDES;
TUMOR CELLS, CULTURED;
|
EID: 0037072302
PISSN: 00062960
EISSN: None
Source Type: Journal
DOI: 10.1021/bi0202530 Document Type: Article |
Times cited : (115)
|
References (33)
|